Dhruv Khullar

So I can see, you know, in the next five or 10 years that there are many versions of these medications and they're much more widely used.

Yeah, I mean, I think we are in an era where we are seeing enormous advances in technology and biomedicine.

I think artificial intelligence is going to play a larger and larger role, not just in the delivery of health care, but also the development of new medications.

This raises a couple thoughts for me.

I mean, the first is that we should do our best to harness the positive aspects of these technologies, and that requires rigorous study of them.

There will be any number of claims that are out in the public sphere, but without doing the controlled, careful study of these types of interventions.

it's going to be very hard to say which claims are true and which are not.

And I think we need that more than ever today when there are so many different sources of medical authority, so many different ways in which people access medicine, so many different channels through which they're getting information about their health.

And so I think a really important part of this next phase is going to be not just how to develop these interventions, but how to study them in the real world.

People are excited about the potential to take advantage of new technologies or interventions.

They want to lean more into health and longevity.

And I think that, in a way, is a great thing.

I think if we're going to have a market in which people are accessing medicines in the way that they are today,

then there's going to be any number of claims that are made about these types of things.

And I think it's incumbent on us to make sure that people have the information that they need to make those decisions about their health.

I think both are going to happen.

I mean, I think there's going to be a lot more insistence that people are able to access these things even outside of the traditional medical system.

I think one thing that it drives home for me is that as doctors or other clinicians, it's no longer going to be effective simply to state

the evidence or to state a recommendation.

That really has to come paired with a rationale, a perspective, you know, demonstration of why it is that the recommendation that we are giving is what it is.